FC
KRYS icon

FORA Capital’s Krystal Biotech KRYS Stock Holding History

FORA Capital’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.48M Buy
5,732
+3,620
+171% +$963K 0.11% 189
2025
Q4 		$521K Buy
+2,112
New +$445K 0.06% 292
2024
Q2 		– Sell
-5,936
Closed -$1.06M – 461
2024
Q1 		$1.06M Buy
+5,936
New +$825K 0.09% 235
2023
Q3 		– Sell
-8,427
Closed -$989K – 528
2023
Q2 		$989K Buy
+8,427
New +$860K 0.14% 163

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FORA Capital's KRYS Position: Q1 2026 in Review

FORA Capital increased its Krystal Biotech (KRYS) stake by 171% in Q1 2026, buying an estimated $963K and bringing the position to 5,732 shares worth $1.48M. The position accounts for 0.11% of the portfolio, ranked #189.

FORA Capital first reported a position in KRYS in Q2 2023 and has held it in 4 quarters since. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • FORA Capital held 5,732 shares of Krystal Biotech worth $1.48M as of Q1 2026.
  • FORA Capital bought 3,620 Krystal Biotech shares in Q1 2026, an estimated $963K.
  • Krystal Biotech made up 0.11% of FORA Capital's portfolio in Q1 2026, its #189 holding.
  • FORA Capital first reported a position in Krystal Biotech in Q2 2023 and has held it in 4 quarters since.
  • 367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on FORA Capital's 13F filing for Q1 2026, filed 15 May 2026.